Scienmag

APRIL 25, 2022

GALVESTON, Texas – Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS–COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community. Latest News Antibodies antibody antiSARSCoV2 common shows study therapy UTMB

Antibody 63

Antibody Allergies Research 63

Scienmag

MAY 4, 2022

LA JOLLA, CA—Getting sick with a common cold doesn’t make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 and MERS-CoV viruses, all of which are closely related.

Antibody 83

Antibody Scientist Research Medicine 83

Scienmag

MAY 13, 2022

LA JOLLA, CA—Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus. Medicine & Health antibody COVID19 explain J08 potent research scientists Scripps

Antibody 87

Antibody Scientist Life Science Trials 87

Scienmag

MARCH 21, 2022

An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. Biology antibody developing hantavirus promise shows treatment

Antibody 82

Antibody Development Medicine Research 82

Scienmag

DECEMBER 27, 2021

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

Antibody 82

Antibody Scientist Protein Vaccination 82

Bio Pharma Dive

JUNE 16, 2021

The biotech said it will seek an expanded FDA clearance after results from the RECOVERY trial showed its antibody can lower mortality among certain hospitalized COVID-19 patients

Antibody 263

Antibody Trials 263

Bio Pharma Dive

SEPTEMBER 17, 2021

The expanded authorization comes amid surging demand for antibody treatments, particularly in states with lower rates of coronavirus vaccination

Antibody 207

Antibody Vaccination Vaccine 207

Bio Pharma Dive

NOVEMBER 5, 2020

Fast antibody testing, however, is spotty The drug, now being considered for emergency clearance by the FDA, seems to work best in patients whose immune systems haven't responded to infection.

Antibody 248

Antibody Drugs 248

Scienmag

APRIL 13, 2022

Medicine & Health antibody COVID19 current mice nasal outperforms spray treatmentsA new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St.

Antibody 83

Antibody Protein Clinical Trials Clinical Trials 83

Scienmag

JANUARY 24, 2022

Cancer antibody bone Engineered metastasis peptide targetsHOUSTON – (Jan. 24, 2022) – A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone.

Engineer 82

Engineer Antibody Drugs Research 82

Bio Pharma Dive

NOVEMBER 9, 2020

The Food and Drug Administration cleared the company's synthetic antibody treatment, but short supplies and logistical challenges could limit its initial impact

Antibody 268

Antibody Drugs 268

Bio Pharma Dive

FEBRUARY 10, 2021

In a late-stage study of people recently diagnosed with COVID-19, the dual-antibody drug sharply reduced the risk of hospitalizations and death

Antibody 248

Antibody Drugs 248

Scienmag

APRIL 20, 2022

BOSTON – According to new research from Boston Medical Center, the antibody function known as antibody dependent cellular cytotoxicity (ADCC) and the ADCC sensitivity of HIV strains may influence the transmission of HIV from mother to child during breastfeeding. Latest News ADCC antibody breastfeeding cellular child cytotoxicity dependent function HIV mother prevent transmission

Antibody 63

Antibody Vaccination Vaccine Research 63

Scienmag

MARCH 23, 2022

Technology and Engineering Antibodies approach COVID19 madeinCanada trackingWith every quiet pass of the robotic arm in a research lab at the Lunenfeld-Tanenbaum Research Institute (LTRI) in downtown Toronto, more questions about COVID-19 are being answered.

Antibody 82

Antibody Research Engineer 82

Scienmag

MAY 6, 2022

Latest News antibody blunts COVID19 obesity response severe study suggests VaccinesNew research being presented at this year’s European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that adults (aged 18 or older) with severe obesity generate a significantly weaker immune response to COVID-19 vaccination compared to those with normal weight. The study is by Professor Volkan Demirhan Yumuk from Istanbul University in Turkey […].

Antibody 62

Antibody Immune Response Vaccination Vaccine 62

Bio Pharma Dive

FEBRUARY 11, 2022

Distribution of Lilly's earlier antibody treatments was halted as testing showed them ineffective against omicron. Bebtelovimab appears able to neutralize the variant, and was authorized by the FDA on Friday

Antibody 225

Antibody 225

Bio Pharma Dive

MARCH 29, 2022

The French pharmaceutical giant has inked its third antibody-focused deal since December, this time betting on a Californian biotech trying to pioneer a new class of medicines

Antibody 130

Antibody Medicine Drugs 130

Scienmag

MARCH 24, 2022

Mayo Clinic researchers have validated a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. An antibody typically consists of two immunoglobulin heavy chains and […]. Latest News antibody Clinic develop diagnose Mayo researchers testROCHESTER, Minn. Nearly 1 million people in the U.S. are affected by MS, according to the National Multiple Sclerosis Society.

Antibody 63

Antibody Clinical Research Development Research 63

Bio Pharma Dive

JUNE 18, 2021

drugmaker is the latest to invest large sums of money in antibody-drug conjugates, following recent deals by Gilead, Merck and AstraZeneca The U.S.

Antibody 274

Antibody Drugs 274

Bio Pharma Dive

DECEMBER 8, 2021

Evusheld, a combination of two antibodies, is meant to be long-acting, proving protective against disease through six months in clinical testing

Antibody 161

Antibody 161

Scienmag

MARCH 24, 2022

A new study shows how antibodies select the antigens that they bind to, as they navigate the surface of pathogens like coronaviruses. Medicine & Health Antibodies child model navigate pathogen play shows surfaces

Antibody 83

Antibody Research Medicine 83

Bio Pharma Dive

JULY 28, 2021

The acquisition is the third Amgen has made since March and broadens its ability to develop bispecific antibodies, a drug class of intense interest to big biotech

Antibody 244

Antibody Development Drugs 244

Bio Pharma Dive

APRIL 19, 2021

Adagio Therapeutics, a well-financed spinout of antibody developer Adimab, could challenge Regeneron and Eli Lilly if its drug candidate proves protective in clinical tests

Antibody 265

Antibody Development Drugs 265

Bio Pharma Dive

MAY 24, 2021

Pharma and biotech companies alike see potential in using bispecific antibodies for hard-to-treat cancers like leukemia, myeloma and solid tumors

Antibody 255

Antibody Drugs 255

Scienmag

NOVEMBER 2, 2021

However, in a newly published study, researchers at the University of Maryland School of Medicine (UMSOM) have detected antibodies primarily made in response to infections in the mucous membranes — in such areas as […].

Antibody 82

Antibody Research Medicine 82

Bio Pharma Dive

DECEMBER 23, 2021

The decision follows worrisome results in lab studies that indicated omicron can evade both drugs and leaves the U.S. with fewer treatments to respond to the variant's spread

Antibody 274

Antibody Drugs 274

Bio Pharma Dive

OCTOBER 14, 2020

Research for the drug, now cleared as Inmazeb, helped Regeneron jumpstart its fast development of an antibody therapy for COVID-19

FDA Approval 198

FDA Approval Antibody Development Research 198

Bio Pharma Dive

MARCH 25, 2021

Treatments from Lilly and Regeneron that combine two different antibodies should be used instead, according to health officials

Antibody 221

Antibody 221

Scienmag

DECEMBER 7, 2021

Antibodies against the SARS-CoV-2 spike protein produced by the immune system can help identify and fend off future infections, but not all antibodies are the same. Latest News Antibodies COVID19 infection vaccination variants yieldsWashington, D.C. People who either recovered from COVID-19 early in the pandemic or received a current vaccine may not be able to fend off new and emerging variants. […].

Antibody 63

Antibody Protein Vaccination Vaccine 63

NY Times

FEBRUARY 11, 2022

The federal government has ordered 600,000 doses of the monoclonal antibody treatment, which is meant for high-risk Covid patients early in their illness. Eli Lilly and Company Antibodies Food and Drug Administration Coronavirus Omicron Variant Drugs (Pharmaceuticals) Coronavirus (2019-nCoV

Antibody 76

Antibody Drugs 76

Bio Pharma Dive

NOVEMBER 5, 2020

Buying VelosBio is Merck's second investment in so-called antibody-drug conjugates since September, reflecting the drug class' fast turnaround

Antibody 257

Antibody Drugs 257

Scienmag

APRIL 10, 2022

Abstract: CT003 Researchers from The University of Texas MD Anderson Cancer Center showed that natural killer (NK) cells derived from donated umbilical cord blood, combined with a novel bispecific antibody known as AFM13 that targets CD16A and CD30, achieved effective responses in patients with pretreated and refractory CD30+ lymphoma. Latest News antibody bispecific cells combined lymphoma Patients response showed strong

Antibody 63

Antibody Research 63

NY Times

MARCH 6, 2022

Shortages AstraZeneca PLC Immune System Antibodies Coronavirus (2019-nCoV) Chronic Condition (Health) Drugs (Pharmaceuticals) Transplants United States Politics and Government

Antibody 82

Antibody Doctors Doctor Vaccination 82

Scienmag

JANUARY 26, 2022

Biology antibody antiCOVID current Drugs effective Omicron pills workMADISON, Wis. — The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. Credit: University of Wisconsin-Madison MADISON, Wis. —

Antibody 82

Antibody Drugs 82

Scienmag

APRIL 22, 2022

Latest News Antibodies COVID19 generates interval longer times Vaccines**Note: this is a press release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April). Please credit the conference if you use this story** New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that […].

Antibody 63

Antibody Vaccination Vaccine Research 63

Pharma Phorum

JULY 6, 2021

Nina Garrett, R&D director at Abingdon Health discusses the key role antibody testing is playing in the pandemic and how an integrated approach with vaccines could help normal life resume. This is where antibody tests come in. Neutralising Antibodies.

Antibody 91

Antibody Immune Response Protein Vaccination 91

Scienmag

FEBRUARY 7, 2022

COVID-19 patients usually develop antibodies (immunity proteins that are specifically […]. Technology and Engineering accuracy antibody biologists coronavirus form improve isolated nucleoprotein pure sensitivity tests

RNA 83

RNA Antibody Protein Development 83

Scienmag

MARCH 30, 2022

Now, researchers reporting in ACS Infectious Diseases have shown that infections with two different HCoVs don’t generate antibodies that effectively cross-react with SARS-CoV-2. Latest News Antibodies common coronavirus dont effective generate infections SARSCoV2Although SARS-CoV-2 has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease.

Antibody 62

Antibody Research 62

Bio Pharma Dive

JANUARY 12, 2021

Moderna and Gilead reported billions in sales for their coronavirus treatments, but Regeneron's antibody drug cocktail hasn't gained traction.

Antibody 245

Antibody Sales Vaccination Vaccine 245

NY Times

FEBRUARY 9, 2021

internal-essential Drugs (Pharmaceuticals) Antibodies Coronavirus (2019-nCoV Researchers hope Eli Lilly’s new combination therapy may be better able to fight virus variants than a similar treatment already in use.

Antibody 83

Antibody Research Drugs 83